SkinHealth Systems Inc. (NASDAQ:SKIN), is not the largest company out there, but it received a lot of attention from a substantial price increase on the NASDAQCM over the last few months. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. As a stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, what if the stock is still a bargain? Let’s take a look at SkinHealth Systems’s outlook and value based on the most recent financial data to see if the opportunity still exists.
The stock seems fairly valued at the moment according to our valuation model. It’s trading around 6.82% above our intrinsic value, which means if you buy SkinHealth Systems today, you’d be paying a relatively reasonable price for it. And if you believe that the stock is really worth $15.69, there’s only an insignificant downside when the price falls to its real value. Although, there may be an opportunity to buy in the future. This is because SkinHealth Systems’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.
Check out our latest analysis for SkinHealth Systems
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by 87% over the next year, the near-term future seems bright for SkinHealth Systems. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
Are you a shareholder? SKIN’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?
Are you a potential investor? If you’ve been keeping an eye on SKIN, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
So while earnings quality is important, it's equally important to consider the risks facing SkinHealth Systems at this point in time. Every company has risks, and we've spotted 1 warning sign for SkinHealth Systems you should know about.
If you are no longer interested in SkinHealth Systems, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.